Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

Finasteride is made through a series of chemical reactions starting from a specific intermediate compound.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Finasteride effectively prevents hair loss and promotes hair growth in men with androgenetic alopecia.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

New tests detect finasteride and dutasteride in urine quickly and easily.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Higher DHT levels and family history lead to earlier hair loss in women.

Mesotherapy with dutasteride effectively treats hair loss with manageable side effects.

Testosterone and dihydrotestosterone can slow down the growth of certain hair follicle cells.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Dutasteride safely treats hair loss without harming sexual function.

Finasteride effectively thickens hair in men with minimal side effects.